1992
DOI: 10.1016/0165-1838(92)90031-b
|View full text |Cite
|
Sign up to set email alerts
|

Cyclophosphamide cystitis in rats: involvement of capsaicin-sensitive primary afferents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

8
64
1
1

Year Published

1996
1996
2011
2011

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 96 publications
(74 citation statements)
references
References 21 publications
8
64
1
1
Order By: Relevance
“…It is known that NK 1 antagonists (13) and B 2 bradykinin antagonists (19) increase bladder capacity and decrease micturition frequency by acting on the spinal cord in this model. Moreover, CYPinduced detrusor hyperreflexia is abolished when the sensory nerve is functionally impaired by pretreatment of rats with high dose capsaicin (20). Thus, CYPinduced detrusor hyperreflexia is thought to be mediated through stimulation of capsaicin-sensitive afferent neurons.…”
Section: Discussionmentioning
confidence: 89%
“…It is known that NK 1 antagonists (13) and B 2 bradykinin antagonists (19) increase bladder capacity and decrease micturition frequency by acting on the spinal cord in this model. Moreover, CYPinduced detrusor hyperreflexia is abolished when the sensory nerve is functionally impaired by pretreatment of rats with high dose capsaicin (20). Thus, CYPinduced detrusor hyperreflexia is thought to be mediated through stimulation of capsaicin-sensitive afferent neurons.…”
Section: Discussionmentioning
confidence: 89%
“…In contrast, increases in PGD 2 in the urinary bladder were biphasic, occurring with both acute (4 h) and chronic CYP treatment but not acute (48 h) treatment (14). Animal studies have also indicated that CYP treatment (acute treatment) in the rat induces increased frequency of voiding in awake rats and urinary bladder hyperreflexia in anesthetized rats (14,(21)(22)(23)26), and these changes are maintained with acute (48 h) and chronic CYP treatment. Thus CYP treatment represents a noxious, chemical irritation of the urinary bladder that also induces bladder overactivity.…”
Section: Discussionmentioning
confidence: 97%
“…Numerous studies involving a chemically (cyclophosphamide; CYP)-induced bladder inflammation (Cox, 1979;Maggi et al, 1992;Lantéri-Minet et al, 1995;Vizzard, 2000a;Vizzard, 2000d;Zvarova and Vizzard, 2006) model have demonstrated alterations in neurochemical (Vizzard, 2000a;Vizzard, 2000dVizzard, , 2001Zvarova and Vizzard, 2006), electrophysiological (Jennings and Vizzard, 1999;Yoshimura and de Groat, 1999), organizational (Vizzard and Boyle, 1999;Vizzard, 2000b) and functional properties of bladder afferent neurons in dorsal root ganglia (DRG) and in central reflex micturition pathways as well as changes in the urinary bladder (xx). Neurotrophins, including nerve growth factor (NGF) have been implicated in mediating some of these changes.…”
Section: Introductionmentioning
confidence: 99%